MedPath

Investigation of the efficacy of read-through therapy for Nagashima-type palmoplantar keratosis using topical aminoglycoside

Not Applicable
Conditions
agashima-type palmoplantar keratosis
Registration Number
JPRN-UMIN000018677
Lead Sponsor
Hokkaido University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
6
Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients who meet exclusion criteria of the drug. 2.Patients with severe complications who need hospitalization. 3.Patients who is considered to be inappropriate for this study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Improvement of skin symptoms such as erythema and hyperkeratosis. 2.Participants' self-assessment of improvement by VAS (Visual Analogue Scale). We evaluate skin symptoms 4 weeks after the treatment.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath